Calendar Cybin Inc.

Equities

CYBN

CA23256X4075

Biotechnology & Medical Research

Market Closed - Nyse Other stock markets 04:00:00 2025-12-12 pm EST			5-day change	1st Jan Change
6.680 ^USD	+6.03%		+11.52%	-24.26%

Nov. 18	Cybin Inc., Q2 2026 Earnings Call, Nov 13, 2025
Nov. 13	Cybin Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

Chart calendar Cybin Inc.

101af92f23835c5d3504d116891f.-6GgEs4EoXC2RWgd3r4IiMh5mTRtq8m6eJjahEm4tuo.qNKQIKBB4hiPFlxKtOhO7aUUoXY57KyKFdaK7yf-6azD489G9mbkR9I3Dw~81aef586b8cf374f0101f4d4d7d52651

Upcoming events on Cybin Inc.

2026-02-16	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-06-30	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-05	Q1 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-15	Q2 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Cybin Inc.

2025-11-17	Jefferies Global Healthcare Conference
2025-11-13	Q2 2026 Earnings Call
2025-11-13	Q2 2026 Earnings Release
2025-11-10	Guggenheim Healthcare Innovation Conference
2025-11-05	Milken Institute Future of Health Summit
2025-11-04	Investor Meeting
2025-09-17	TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
2025-09-08	H.C. Wainwright Global Investment Conference
2025-09-05	Cantor Global Healthcare Conference - Fireside Chat
2025-08-18	Annual General Meeting
2025-08-13	Q1 2026 Earnings Release
2025-08-12	Canaccord Genuity Growth Conference - Fireside Chat
2025-06-30	Q4 2025 Earnings Release
2025-06-19	Psychedelic Science Conference
2025-06-16	H.C. Wainwright Neuro Perspectives Conference - Fireside Chat
2025-05-29	Water Tower Research Conference - Fireside Chat
2025-05-21	AGP Virtual Healthcare Conference
2025-05-05	Milken Institute Global Conference
2025-02-10	Q3 2025 Earnings Release
2025-01-13	Lytham Partners Investor Healthcare Summit

Annual results

Fiscal Period	March	2023	2024	2025	2026	2027	2028
Net sales Million CAD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	22,5
EBITDA Million CAD	Released Forecast Spread	-46,6 -43,7 -6.71%	-78,4 -67,4 -16.42%	-143 -133 -7.39%	-165	-212	-219
EBIT Million CAD	Released Forecast Spread	-51,5 -50,8 -1.43%	-78,8 -68,9 -14.4%	-143 -128 -11.54%	-164	-215	-212
Earnings before Tax (EBT) Million CAD	Released Forecast Spread	-47,5 -47,0 -0.97%	-78,1 -74,7 -4.54%	-113 -108 -4.59%	-171	-209	-217
Net income Million CAD	Released Forecast Spread	-47,5 -46,7 -1.72%	-78,1 -74,5 -4.75%	-113 -111 -2.35%	-169	-198	-217
EPS CAD	Released Forecast Spread	-9,88 -9,06 -9.09%	-9,50 -8,99 -5.63%	-5,59 -3,80 -47.17%	-4,36	-3,11	-3,05
Announcement Date		27/06/23	26/06/24	01/07/25	-

Quarterly results

Fiscal Period	September	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million CAD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00	0,00	0,00	0,00
EBITDA Million CAD	Released Forecast Spread	-25,1 -14,0 -79.59%	-20,2 -17,8 -13.37%	-58,1 -18,4 -216.04%	-31,2 -21,5 -45.3%	-33,2 -23,4 -41.92%	-33,8 -24,6 -37.6%	-40,4 -24,3 -66.77%	-43,2	-46,6	-53,1	-57,3	-68,5	-69,9
EBIT Million CAD	Released Forecast Spread	-25,2 -18,0 -40.02%	-20,3 -20,9 2.99%	-58,3 -19,5 -198.65%	-31,3 -30,6 -2.37%	-33,3 -26,6 -25.07%	-33,9 -26,9 -25.85%	-40,5 -34,5 -17.37%	-43,4	-45,6	-49,6	-52,5	-57,6	-57,1
Earnings before Tax (EBT) Million CAD	Released Forecast Spread	-21,3 -18,0 -18.81%	-14,8 -20,0 25.85%	-57,2 -19,1 -199.81%	-10,5 -34,7 69.66%	-50,6 -25,6 -97.35%	-33,9 -27,1 -25.03%	-47,3 -34,3 -37.74%	-44,4	-45,1	-47,7	-50,9	-55,5	-53,8
Net income Million CAD	Released Forecast Spread	-21,3 -18,4 -16.31%	-14,8 -20,0 25.85%	-57,2 -19,1 -199.81%	-10,5 -34,7 69.66%	-50,6 -26,1 -94.14%	-33,9 -28,1 -20.8%	-47,3 -33,9 -39.58%	-43,4	-44,0	-45,1	-47,3	-50,4	-49,3
EPS CAD	Released Forecast Spread	-0,76 -1,58 52%	-0,76 -1,33 42.86%	-2,86 -0,96 -198.95%	-0,53 -1,72 69.25%	-1,46 -1,20 -21.67%	-1,10 -1,03 -6.8%	-1,95 -1,44 -34.98%	-0,82	-0,79	-0,82	-0,83	-0,77	-0,72
Announcement Date		26/06/24	08/08/24	13/11/24	11/02/25	01/07/25	13/08/25	13/11/25	-	-	-	-	-	-

Upcoming sector events for Cybin Inc.

2026-01-14	BIOCON LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-04	ANAVEX LIFE SCIENCES CORP.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-05	GENMAB A/S	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-02-09	EXELIXIS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-09	ARROWHEAD PHARMACEUTICALS, INC.	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-10	VIKING THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-10	REZOLUTE, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-11	AGIOS PHARMACEUTICALS, INC.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-11	PROTHENA CORPORATION PLC	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-02-15	INVENTIVA	Q4 2025 Sales and Revenue Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Cybin Inc.

Today	SANBIO COMPANY LIMITED	Q3 2025 Earnings Release
2025-12-08	LUMOSA THERAPEUTICS CO., LTD.	November 2025 Sales and Revenue Release
2025-12-05	PHARMAESSENTIA CORPORATION	November 2025 Sales and Revenue Release
2025-12-05	TAIMED BIOLOGICS INC.	November 2025 Sales and Revenue Release
2025-12-04	MAPLIGHT THERAPEUTICS, INC.	Q3 2025 Earnings Release
2025-12-03	KALVISTA PHARMACEUTICALS, INC.	Q2 2026 Earnings Release (Projected)
2025-11-25	ARROWHEAD PHARMACEUTICALS, INC.	Q4 2025 Earnings Release
2025-11-21	INVENTIVA	Q3 2025 Sales and Revenue Release
2025-11-17	IMMATICS N.V.	Q3 2025 Earnings Release
2025-11-14	SCHOLAR ROCK HOLDING CORPORATION	Q3 2025 Earnings Release